Inactive Instrument
DIAL BIORFD Stock Nasdaq Stockholm
Stocks
DIABIO BTA
SE0019173832
Biotechnology & Medical Research
| 1 day | +2.99% |
| Manager | Title | Age | Since |
|---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 2023-11-22 |
Fata Mrsic
DFI | Director of Finance/CFO | - | 2024-06-13 |
Emelie Danefur
CTO | Chief Tech/Sci/R&D Officer | - | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 41 | 2020-12-31 | |
| Chairman | 70 | 2020-12-31 | |
Kushagr Punyani
BRD | Director/Board Member | 35 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.99% | +15.00% | - | - | 705K | ||
| -2.49% | -6.35% | +51.07% | +64.95% | 65.42B | ||
| -0.63% | -2.91% | +6.20% | +89.22% | 58.91B | ||
| -2.37% | -2.22% | +22.87% | +82.31% | 55.24B | ||
| -1.06% | -4.69% | +13.66% | +111.31% | 45.66B | ||
| -0.67% | -6.07% | +14.70% | +21.31% | 41.29B | ||
| -0.93% | +1.67% | +20.83% | +45.03% | 36.82B | ||
| +1.86% | -5.06% | +134.07% | +652.74% | 34.48B | ||
| -0.80% | +0.61% | +77.26% | +56.26% | 32.5B | ||
| +0.63% | +19.64% | -27.39% | +488.77% | 31.69B | ||
| Average | -0.31% | -0.66% | +34.81% | +179.10% | 45B | |
| Weighted average by Cap. | -0.91% | -1.28% | +32.92% | +152.98% |
Employees
4
















